1 / 35

Neonatal Herpes Simplex Infections

Neonatal Herpes Simplex Infections. MAJ Mark Burnett Pediatric ID Fellow MAR 2003. Neonatal Herpes. Background A Case Study Types of Infections Risks of Infection Diagnostics Treatment Summary. “Herpes” – from the Greek “to creep, crawl”

stacy
Download Presentation

Neonatal Herpes Simplex Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neonatal Herpes Simplex Infections MAJ Mark Burnett Pediatric ID Fellow MAR 2003

  2. Neonatal Herpes • Background • A Case Study • Types of Infections • Risks of Infection • Diagnostics • Treatment • Summary

  3. “Herpes” – from the Greek “to creep, crawl” “Herpetic eruptions” described as early as 100 AD 1960’s – HSV1 and HSV2 differentiated HHV1 – HSV1 HHV2 – HSV2 HHV3 – VZV HHV4 – EBV HHV5 – CMV HHV6 – Causes? HHV7 – HHV8 - Herpes Infections

  4. A Case Study – A.B. • Term infant born to a 22 y/o GBS+ mother with no Pmhx of HSV-2 • 4 doses of IV PCN given PTD • ROM <18 hours PTD, no maternal fevers • Forceps delivery • APGARS of 9/9 • Well until fever to 101.7 at 30 hrs of life • Fever work-up initiated

  5. A.B. • WBC 23K (50S 2B 38L) • AST 98 ALT 92 • CSF 48 WBC 2650 RBC Pro 93/Glu 53 • HSV PCR, Enteroviral PCR, HSV Surface cx – sent • Exam unremarkable • Amp/Gent/Acyclovir initiated • Fevers persisted over next 13 hours, again spiking to 101.5 • AST 147 / ALT 93 two days later

  6. A.B. – additional info • No history of HSV reported in mother, father • Mother without febrile illness • Niece with a “cold sore” visited prior to delivery, and “held the baby” after he was born • LP repeated two days after initial study with normalization of cell count

  7. A New Development

  8. Questions? • What diagnostic tests could we perform, and how reliable are they really? • Would it be worthwhile to run tests on mom? • Is the niece’s “cold sore” a “red herring” – what are the risks? • Bottom line – how worried should we be about HSV, and how would we treat it?

  9. Neonatal HSV • 1 in 2,500-5,000 deliveries / 500-1500 per yr. • Birth to 7 weeks of life • HSV2 = 70-75%, HSV1 = 25-30% • 3 Main Types • Skin, Eye, Mouth (SEM) • CNS • Disseminated Disease (DISSEM) • At Risk: Premature, ROM >6hr, Fetal scalp monitoring • Can be acquired congenitally, during the birth process, and in the post-partum period

  10. Routes of Transmission • 85% via infected maternal genital tract • Ascending infection? • En route • 10% postpartum • 5% (or less) – intrauterine/congenital infection

  11. Congenital HSV • Rare, most devastating • Only 50 cases described • Skin vesicles • Chorioretinitis • Microcephaly • Micro-ophthalmia • IUGR

  12. Skin, Eye, Mouth (SEM) • Approximately ½ of all HSV infections • 1st-2nd week presentation • Limited to skin, eye, mouth/mucous membranes • 60-70% of untreated patients progress to CNS/disseminated disease

  13. SEM (cont) • Long term neurologic sequelae seen in 30% of cases – even if treated • Ophthalmology involvement

  14. “Presenting Part” (SEM)

  15. Scalp Monitors

  16. HSV - CNS Disease • Encephalitis without visceral involvement, mainly involving the temporal lobes • Early to 3rd week of life presentation • Skin lesions may appear late, if at all • 35% of all cases, only 2-5% untreated survive normally

  17. Radiographic Findings

  18. Disseminated Disease • Approximately 20% of all infections • Hepatitis • Pneumonitis • DIC • Infant may be ill on first day of life • Skin lesions appear late, or not at all

  19. Signs

  20. Postnatal acquisition • Most commonly HSV1 • Moms with HSV • Mask • Breastfeeding – O.K. if without lesions • The Mohel and the Mezizah

  21. Contacts • “Personnel with an active herpetic whitlow should not have direct patient care of neonates”. • Family transmission has been described

  22. Morbidity and Mortality

  23. Stretch Break

  24. Take Home Message • Infection is most common when a mother develops a genital infection late in pregnancy ( her primary HSV1 or HSV2 infection) – then delivers before the development of protective maternal antibodies

  25. Herpes Simplex • Approximately 5% of the general population has been diagnosed with genital herpes – but approximately 20-30% of women may be infected with HSV-2 • Viral shedding occurs without identifiable lesions on 1-3% of days

  26. Maternal Testing? • Identify discordant couples to avoid transmission in the third trimester • If mom is HSV1/HSV2 negative • If mom is HSV2 negative • If mom is HSV2 positive – risk is low for a vaginal delivery? • Is testing after delivery going to be helpful? • Will blood tests of the baby be helpful, or just reflect mom’s status? • Psychosocial ramifications?

  27. Herpes during Pregnancy • As many as 2% of pregnant women are infected with HSV2 during pregnancy • 25% of women with a history of genital herpes have an outbreak at some time during their pregnancy, 11-14% at time of delivery • 36% at delivery for those with first infection! • Virus is recovered from 1% of asymptomatic women at delivery

  28. What is the risk? • Vaginal delivery when mom has presence of first symptomatic lesions – 50% • Vaginal delivery when mom is asymptomatic, but is newly infected – 33% • Vaginal delivery when mom has recurrent lesions – 4% • Vaginal delivery when mom has a history of herpes lesions in past, none presently – 0.04%

  29. OB Management • 70’s-80’s – weekly HSV cultures • 1988 – patient examined at delivery, Cesarean delivery if: (no data) • Identifiable genital lesions • Patient describes prodromal symptoms • Vaginal delivery for those with hx only • Primary infection diagnosed - treat • Estimated $2-4 million to prevent each case • 20-30% of infants who are diagnosed with neonatal herpes are delivered by Cesarean delivery

  30. Diagnostics • HSV Cx – positive in 1-2 days (cytopathic effect) • DFA – sensitivity/specificity in the 75%-85% range

  31. PCR Testing • Detects minute amounts of DNA, RNA • DISSEM – 93% • CNS – 76% • SEM – 24% • False negative may occur if CSF is obtained “too early” • Order through IVF!

  32. Diagnostics (cont) • Surface cultures • Mouth (40-50%) • Eyes (25%) • Rectum • Skin • Cultures • Stool • Urine • CSF >100 WBC/Inc. Pro • Tzanck – neither sensitive nor specific

  33. Treatment - Acyclovir • SEM infections • 60mg/kg/day divided q8h for 14 days • May be lengthened to 21 days in the near future • Oral Acyclovir needed later in life? • DISSEM and CNS HSV infections • 60mg/kg/day divided q8h for 21 days • Re-tap if CNS disease exists prior to d/c • Watch for neutropenia – 2x week ANCs

  34. Questions / Controversies • Would maternal “pre-treatment” change the time /clinical presentation of HSV? • Should an infant delivered vaginally to a mother with active lesions be treated? • Can HSV be resistant to Acyclovir?

  35. Take Home Messages • Most neonates with HSV infection are born to mothers with asymptomatic genital shedding at delivery, with no history of genital herpetic lesions • No one test is 100% sensitive / specific • Keep HSV in mind • How would you manage our case?

More Related